Diagnosis, Mechanisms, and Risk for Recurrence in Siblings |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
CONTENTS |
|---|
|
|
|---|
Introduction
Sudden, Unexpected Death in Infancy
Explained by Autopsy
Unexplained by Autopsy
Summary
Recurrent Infant Mortality in Siblings
Explained Causes
Unexplained Causes
Summary and Critique
Obstructive Sleep Apnea Syndrome
Family Studies
Summary and Critique
Physiological Studies
Siblings of a Previous SIDS Victim
Parents of SIDS Victims
Summary and Critique
Implications
The risk of sudden infant death syndrome (SIDS) recurring in siblings of SIDS victims is controversial. The mortality studies of recurrent SIDS have been considered inconclusive and criticized on methodological grounds, and the family studies in siblings and parents of SIDS have yielded inconsistent results. How often intentional suffocation has been misdiagnosed as (recurrent) SIDS is unknown because there are no objective diagnostic criteria. Some health professionals have stated that only homicide runs in families and that all second cases of SIDS in a family should be investigated for intentional suffocation (1).
The purpose of this report is to review the evidence and possible mechanisms for sudden unexpected infant death and SIDS in siblings. Relevant data were obtained from published articles about SIDS and electronic searches for infant mortality, child abuse, infant homicide (filicide), Munchausen syndrome by proxy, sleep, and genetics. Exclusions included SIDS deaths at younger than 1 wk or older than 1 yr of age, studies published before 1970 or not published in English, and reports without a control group.
| |
SUDDEN, UNEXPECTED DEATH IN INFANCY |
|---|
|
|
|---|
Explained by Autopsy
Natural. In a cohort of sudden unexpected deaths including unintentional (accidental) deaths, 18% were explained by a "thorough case investigation" (4) compared with 20% explained among sudden unexpected deaths excluding unintentional deaths (5). Infections were the most frequent natural cause (Table 1).
|
Unintentional. These deaths are typically identified by the history and autopsy findings. Unintentional deaths accounted for 15% of all explained causes of sudden unexpected death in infancy in a population-based case-control study (4).
Traumatic child abuse (Filicide). Male caretakers are usually the perpetrators. Also called "shaken baby syndrome," typical autopsy findings include multiple fractures and intracranial hemorrhage (6). Traumatic filicide accounted for 13-24% of all explained sudden unexpected deaths.
Unexplained by Autopsy
Sudden infant death syndrome (SIDS). Pathophysiology. SIDS is defined as the sudden death of an infant younger than 1 year of age that remains unexplained after a thorough case investigation that includes a complete autopsy, examination of the death scene, and review of the clinical history (11) (Table 1). This definition was established in 1969 and revised in 1989 to include scene investigation and clinical history review. Among sudden unexpected infant deaths, 80-82% were diagnosed as SIDS (4, 5). Accounting for 2,529 deaths in 1998 in the United States (12), SIDS is the third leading cause of infant mortality (8.9%) after congenital anomalies (22%) and short gestation/ low birth weight (14%).
There is no autopsy finding pathognomonic of SIDS and no finding required for the diagnosis. There are, however, some common findings (13, 14). Petechial hemorrhages are found in more than 70-90% of cases. Pulmonary edema is often present and may be substantial. Due to lack of uniform criteria among pathologists, some unexpected deaths may be "misdiagnosed" as pneumonia or other natural causes based on minimal findings at autopsy insufficient to explain sudden death.
No single mechanism has been established. It is likely that a number of distinct pathophysiologies may be related to SIDS. A brain stem abnormality related to neuroregulation of cardiorespiratory or other autonomic functions appears to be the most compelling hypothesis (15, 16). Autopsy studies indicating preexisting, chronic low-grade hypoxemia attributed to sleep-related hypoventilation support this hypothesis. The autopsy evidence for chronic hypoxemia includes (a) persistence of adrenal brown fat, hepatic erythropoiesis, brain stem gliosis and other structural abnormalities (13), and (b) multiple neurotransmitter abnormalities in brain stem regions relevant to neural cardiorespiratory regulation (17, 18).
These postmortem studies of neurotransmitter and receptors have identified reduced binding to kainate receptors in the arcuate nucleus, a region of the human ventral medullary surface involved in chemosensitivity to CO2 in experimental animals (17). SIDS victims also have been observed to have decreased binding of serotonin in the nucleus raphe obscurus, a brain structure linked to the arcuate nucleus, and in four other brain regions (18, 19). These brain regions have their origin in a part of the rhombic lip, a region later giving rise to key structures in the brain stem and thought to play a crucial role in regulating arousal responsiveness from sleep, as well as breathing, heart rate, and body temperature.
Deficient kainate binding in the arcuate nucleus and deficient serotonergic receptor binding in the brain stem may be indicative of genetic alterations of normal prenatal development of the brain stem. It is possible, however, that these apparent brain stem abnormalities are secondary to an "upstream" deficit as yet undefined. It is also possible and indeed likely, as discussed later, that these neurotransmitter abnormalities represent interaction(s) between environmental risk factors and susceptibility genes associated with autonomic dysregulation.
Deficient inflammatory responsiveness to infection and allergic reactions have also been hypothesized to be a cause of SIDS (20). SIDS victims with mild upper respiratory infections are more likely to have deletions of either complement C4A or the C4B gene than control subjects (21). Partial deletions in the C4 genes may thus contribute to the link between upper respiratory infection and SIDS (16). Mast cell degranulation has been reported in SIDS victims, implying degranulation in the immediate hours before death and hence consistent with anaphylaxis (22, 23). Family members of some SIDS victims also have increased mast cell hyperreleasability and degranulation (24), further supporting anaphylaxis and allergic mediators as a possible cause for SIDS and indicating a genetic mechanism.
Additional insights into the pathophysiology of SIDS are suggested by physiological studies of groups considered to be at increased risk for SIDS, including infants with idiopathic apparent life-threatening events (ALTE) and premature infants (15, 16). The abnormalities observed in these infants, a few of whom later died of SIDS, include frequent/prolonged apnea, diminished chemoreceptor sensitivity to hypercarbia or hypoxia, impaired control of heart and respiratory rate, abnormal heart rate variability and vagal tone, deficient or absent arousal responses from sleep, metabolic abnormalities, infection, and impaired inflammatory response to infectious agents (16, 24).
Genetic susceptibility. Sequencing the 3 billion base pairs containing the 80,000 genes in the human genome will lead to fundamental changes in the way we think about health and disease, including the role of specific gene products in facilitating or permitting adverse pathophysiological responses (25). Achieving consensus on the role of genetic susceptibility in SIDS is not yet possible because there is no consensus as to which pathophysiologies are directly linked to SIDS. To the extent that impaired neural control of breathing is relevant to SIDS, however, data are rapidly accumulating that link gene function in the brain stem to breathing control (26). Adaptation to an environmental risk such as hypoxia, for example, involves complex regulation of gene expression in precise brain stem sites, and normal postnatal cardiorespiratory control at rest depends on genes controlling prenatal development.
Neural control of breathing and sleep are closely integrated, and abnormalities in regulation of sleep and circadian rhythmicity can thus result in impaired cardiorespiratory integration and arousal responsiveness from sleep (27). Circadian rhythmicity has been extensively studied in animals, and homologous counterparts of essential circadian clock genes isolated in Drosophila have been identified in mammals (28). Because the sleep-wake cycle is under control of the circadian clock, these circadian master genes as well other sleep-related genes likely influence sleep regulation (29).
Targeted gene inactivation studies in animals have identified several genes involved with prenatal brain stem development of respiratory control including arousal responsiveness. During embryogenesis, for example, neurotrophins regulate the survival of specific cellular populations composing the respiratory neuronal network (30). The neurotrophins are a multigene family of growth factors encoding closely homologous peptides, and the diversity of neurotrophins is complemented by similar heterogeneity in neurotrophin receptors. Brain-derived neurotrophic factor is required for development of normal breathing behavior in mice and newborn mice lacking functional brain-derived neurotrophic factor exhibit ventilatory depression associated with apparent loss of peripheral chemoafferent input (30, 31). Ventilation is depressed and hypoxic ventilatory drive is deficient or absent (31).
Krox-20, a homeobox gene important for hindbrain morphogenesis, also appears to be required for normal development of the respiratory central pattern generator (26, 32). Krox-20-null mutants exhibit an abnormally slow respiratory rhythm and increased incidence of respiratory pauses, and this respiratory depression can be further modulated by endogenous enkephalins (32). Inactivation of Krox-20 may result in the absence of a rhythm-promoting reticular neuron group localized in the caudal pons and could thus be a cause of life-threatening apnea.
Brain stem muscarinic cholinergic pathways are important in ventilatory responsiveness to CO2. The muscarinic system develops from the neural crest, and the ret protooncogene is important for this development (33). Ret knockout mice have a depressed ventilatory response to hypercarbia, implicating absence of the ret gene as a cause of impaired hypercarbic responsiveness and hence relevant to SIDS (15, 16). Diminished ventilatory responsiveness to hypercarbia has also been demonstrated in male newborn mice heterozygous for Mash-1 (34). There is a molecular link between ret and Mash-1, and the latter is expressed in embryonic neurons before the former in vagal neural crest derivatives and in brain stem locus coeruleus neurons (35), an area involved with arousal responsiveness. Mash-1 thus appears to be involved in respiratory control development via mechanisms linked to the X chromosome. Abnormality of this gene identifies one possible genetic basis for the increased frequency of SIDS in males (36) and for the impaired arousal responsiveness thought to be critically important in the pathophysiology of SIDS (15, 16, 27).
Genetic-environmental interactions. There are abundant data indicating multiple and robust associations between environmental factors and SIDS (4, 16, 36). These associations do not, however, preclude important polygenic mechanisms in which multiple genes interacting in different environments increase or decrease risk for that disorder.
A theoretical analysis of familial aggregation of disease
among siblings concluded that such aggregation was generally
related to genetic factors as clustering of most environmental
risk factors with a relative risk (RR)
10 among relatives
would lead to only slight and often unmeasurable excess aggregation of disease (39). Considering the many well-established examples of clinical conditions with dynamic interactions between genetic susceptibility and environmental influences,
however, it is likely more accurate to consider genetic-environmental interactions as the most important mechanism. In
regard to congenital defects, the combined RR for having the
same defect in the second as in the first sibling in a population-based study was 7.6 (95% confidence interval [CI] 6.5-8.8) and
subanalyses indicated strong indirect evidence of contributions
from environmental factors (40). A significant genetic role is
also suggested, however, by an increased RR for recurrence of
the same congenital defect in offspring as in the mother, when
common environmental influences would be less likely (41).
There are many examples of interactions between genetic susceptibility and environmental factors. Asthma, for example, shows polygenic inheritance and genetic heterogeneity (Table 2) (42). Multiple independent segregating genes are required for phenotypic expression and different combinations of gene variants can contribute to the phenotype in different families. Causal genetic and environmental interactions have also been identified for other common clinical entities (46).
|
|
In regard to SIDS, there are putative interactions between sleep position, soft bedding and blankets, and impaired cardiorespiratory control, especially impaired ventilatory and arousal responsiveness (55). Facedown sleeping occasionally occurs in healthy full-term infants sleeping prone and can result in transient episodes of airway obstruction and asphyxia, but these healthy infants were able to arouse (56). Infants with insufficient arousal responsiveness to asphyxia, however, would be at risk for fatal asphyxia (55). Risk for life-threatening asphyxia from rebreathing can also be increased with soft bedding. Hypercarbia and hypoxemia when sleeping prone have each been observed in studies relating rebreathing or upper airway obstruction to prone sleeping (57).
There also appear to be interactions between sleep position and impaired thermoregulation (60). Facedown sleeping can cause clinically significant thermal stress, which could further compromise infants with deficient cardiorespiratory control or autonomic control, especially with genetic susceptibility to impaired thermoregulation.
Fetal and postnatal exposure to cigarette smoke in animal and human studies is a major risk factor for SIDS (16, 37, 61- 65), especially if associated with polygenic susceptibility. Both lambs and infants demonstrate impaired ventilatory and arousal responsiveness to hypoxia associated with fetal exposure (61, 62, 64), and postnatal nicotine exposure in piglets may interfere with normal autoresuscitation after apnea (68). In addition, fetal rat exposure to maternal smoking reduces protein kinase C within the dorsocaudal brain stem (62), which would impair respiratory control.
Intentional suffocation. The mother is typically the perpetrator, in contrast to traumatic child abuse. Intentional suffocation may be suspected from the case history and scene investigation and may be alleged because of prior sudden and
unexpected infant death(s) in the family, but there are no pathognomonic findings at autopsy (Table 1). Like SIDS, therefore, the diagnosis can neither be confirmed nor excluded at
autopsy. A moderate degree (
5%) of pulmonary hemorrhage has been proposed as an indicator of prolonged airway
obstruction from overlying or intentional smothering (69).
However, alveolar hemorrhage appears to be a characteristic
of sudden unexpected death in a young infant, regardless of
cause of the unexplained death, and hence appears neither
necessary nor sufficient for diagnosis of suffocation (70).
Intentional suffocation may be a form of Munchausen syndrome by proxy in which the abuse is premeditated and may be associated with maternal psychiatric disturbance (71, 72). Intentional suffocation has been documented as a cause of ALTE by covert video surveillance (73, 74) but cannot be diagnosed with certainty in sudden unexpected death unless the perpetrator confesses. A behavioral profile developed for perpetrators of Munchausen syndrome by proxy does seem to be common in mothers guilty of intentional suffocation but the profile is not specific (73).
The incidence of intentional suffocation is unknown (Table 1). In a retrospective and selective referral group of 27 families with 57 sudden unexpected infant deaths (24 families with two, three with three deaths) studied by confidential inquiry, 55% of the deaths were attributed to intentional suffocation, 31% to explained causes including unintentional, 9% to SIDS, and 5% undetermined (75). Among 39 children thought to be victims of life-threatening abuse, covert video surveillance documented abuse in 33 including intentional suffocation in 30 (77%) (74). Among 41 siblings of these 39 children, there were 12 previous sudden unexpected infant deaths; investigations prompted by the video surveillance results led to four parental confessions of eight intentional suffocation and one conviction for deliberate salt poisoning. The population-based incidence of intentional suffocation has been estimated to be as high as 10% of sudden unexpected infant deaths, but is more likely < 5% and may be as low as 2% (6).
Summary
A thorough case investigation including autopsy should identify all explainable causes of unexpected infant death. Fatal child abuse comprises two distinct subgroups: traumatic child abuse explained by postmortem examination and intentional suffocation that cannot be differentiated from SIDS by autopsy.
Missed cases of intentional suffocation notwithstanding, SIDS cases constitute the majority of sudden unexpected deaths in infancy. Extensive pathological and physiological data implicate impaired cardiorespiratory control, especially deficits in arousal from sleep. These neural control systems appear to depend at least in part on genes controlling prenatal development of the brain stem. There are likely important interactions between genetic susceptibility and environmental exposures occurring during fetal development (e.g., cigarette smoking) and postnatal (e.g., prone sleep position, soft bedding, passive smoking).
| |
RECURRENT INFANT MORTALITY IN SIBLINGS |
|---|
|
|
|---|
Explained Causes
The next siblings of first-born infants dying of SIDS are at increased risk for birth-related deaths (76) (Table 3). When considering the specific cause of death in a subsequent sibling, the RR for same cause of death was 9.1 compared with 1.6 for a different cause of death. Among sibling pairs with recurrence of the same cause of death, the RR was significantly increased for all causes except infection. An expert panel reviewed all sudden unexpected infant deaths, but autopsy rates in the index cases were only 50-70%.
|
Autopsy rates were higher in a second study of recurrent infant mortality, 90% in the first and 100% in the next sibling death (77). The results, however, were similar to the first study (76). The RR for postperinatal infant mortality from the same general cause was significantly increased in the next-born and all subsequent siblings for explained causes. This observed increase in RR for recurrent infant mortality related to prematurity is consistent with the observed increased risk of prematurity in second-born siblings when the first-born sibling was premature (78).
In a population-based case-control study of all sudden unexpected infant deaths among 473,000 live births in 1993-1996 (UK) (37), infants with explained deaths were significantly more likely than control subjects to have had a previous sibling death in infancy (OR 5.96, CI 1.29-27.63), but not of having a previous stillbirth. Although scene investigations were not done, this study is strengthened by a 100% autopsy rate among the 456 sudden unexpected deaths, two later home visits by trained interviewers for data collection, a local multidisciplinary case review, and review by a multidisciplinary regional confidential inquiry committee. The inquiry included clinical history, psychosocial factors, gross pathology, histopathology, biochemistry, microbiology, virology, and radiology.
Unexplained Causes
Ten mortality studies have quantified the risk of recurrent SIDS when a prior sibling has died suddenly and unexpectedly (37, 76, 77, 79). The RR for recurrent SIDS in siblings is increased from 3.7 to 10.0 (all differences significant), which is similar to increased risk for recurrence of non-SIDS causes of infant mortality (37, 76, 77). The risk for recurrent SIDS in one study was no longer increased after adjusting for maternal age and birth rank (81), but the study then had insufficient power to detect a difference less than 4-fold.
Increasing parity is associated with higher risk for SIDS, with an odds ratio (OR) of 1.8 and 1.7 for all U.S. births in 1990 and 1996, respectively (CDC, unpublished data). The observed RR for recurrent SIDS, however (Table 3), was 4.6 times greater than expected by the effect of parity alone (76). The recurrence risk for all subsequent siblings is increased to a similar and significant extent as for the next sibling (76, 80, 81). The RR for risk of SIDS was also similar when analyzed for prior siblings (83).
The risk for recurrent SIDS in the twin of a SIDS victim was observed to be six of 625 in one region of South Australia, a rate ratio of 9.6/1,000 twin births (84). In a later cohort of all U.S. births in 1987-1991 with autopsy in all deaths, however, the rate ratio was only 0.004/1,000 twin births, corresponding to an RR of 8.2 (CI 1.2-56.7) for SIDS in the twin of a SIDS victim (85).
Summary and Critique
Subsequent siblings appear to be at increased risk for the same natural cause of infant mortality as the first sibling, except possibly infections. This relationship exists for both expected and unexpected causes of infant death and, among the latter, exists for explained causes and for SIDS. The risk of recurrent SIDS in surviving twins is also increased, but not to any greater extent than in nontwin siblings.
The early mortality studies of sudden unexpected infant deaths have deficits that limit general acceptance of the results, including missing or incomplete autopsy data. The autopsy rate was not provided for index cases in three instances (80) and for subsequent sibling deaths in one instance (80). Further, the rate in index cases was as low as 50% and never > 90%. Of note, however, the autopsy rate in subsequent siblings in four SIDS studies was 100% (77, 79, 81, 82) with results similar to the other studies.
The case-control study of deaths from five regions in England included thorough case investigations for the index death but information regarding prior infant deaths in the family was based on family reports (37). Although not designed as a study of recurrence risk for SIDS in siblings, the results may provide a useful perspective as the thorough investigation of all index cases of sudden unexpected infant death should reduce the number of missed cases of intentional suffocation to the lowest possible level. It is thus noteworthy (Table 3) that SIDS infants were significantly more likely than control infants to have had a previous sibling death during infancy, similar to the studies from Norway and Oregon of recurrent SIDS in siblings (76, 77). In addition, SIDS infants were again more likely than control infants to have had a prior stillbirth.
Another limitation of the mortality studies is that with one exception (37), no prevalence data for epidemiological risk factors associated with SIDS are included (69). It is therefore not possible to determine the extent to which risk for recurrent sudden unexpected death in infancy including SIDS might be related to common environmental risk factors. This is especially relevant now because overall SIDS rates have decreased substantially since the back-to-sleep campaigns and the relative impact of epidemiological factors on risk for SIDS and recurrent SIDS is changing (37, 86, 87).
| |
OBSTRUCTIVE SLEEP APNEA SYNDROME |
|---|
|
|
|---|
Family Cohort Studies
Studies of obstructive sleep apnea syndrome or sleep-disordered breathing in families provide another perspective regarding genetic susceptibility to breathing control problems. Because these studies also suggest an increased risk for SIDS when obstructive sleep apnea aggregates in families, these data may also provide important insight regarding one possible pathophysiological mechanism for SIDS (88). The high percentage of adult children of patients with obstructive sleep apnea syndrome also having obstructive sleep apnea suggests that it may be an inherited syndrome (88). Obstructive sleep apnea syndrome appears to significantly aggregate within families and the risk appears to increase progressively with increasing numbers of affected relatives. This familial aggregation is not explained entirely by similarities in body mass index or neck circumference, suggesting the importance of other familial factors in increasing genetic susceptibility (90). As adults, children of patients with obstructive sleep apnea syndrome appear to have inherited subtle defects that reduce their ability to compensate for increased loads and maintain upper airway patency during sleep (89). Familial sleep-disordered breathing may be based partly on a familial abnormality in ventilatory control associated with blunting of the hypoxic ventilatory response. The greater increase in impedance during inspiratory loading in members of affected families also suggests a propensity for dynamic airway narrowing (89). Among Japanese men with obstructive sleep apnea syndrome, the frequency of HLA-A2 and HLA-B39 is increased, again suggesting an important role for genetic susceptibility (94).
A genetic contribution to the etiology of obstructive sleep apnea syndrome is further suggested by the associated craniofacial dysmorphism (93,95). Adults with obstructive sleep apnea syndrome having a relative with SIDS or ALTE were more likely than affected adults having no relative with SIDS or ALTE to have brachycephaly (p = 0.05), smaller mean posterior nasal spine-basion distance (p = 0.0001), and smaller ratio of anterior mandibular/anterior maxillary dental height (p < 0.05) (92). In this same study of children of index adults with obstructive sleep apnea syndrome and first-second-degree relatives, there was a trend toward higher incidence of SIDS/ALTE in the sleep apnea syndrome index families (10.8% versus 3.2%, p = 0.11) and all 10 SIDS/ALTE events occurred in families with at least one obstructive sleep apnea syndrome (p = 0.03) (Table 5).
|
In further support of a genetic link between SIDS and upper airway compromise, SIDS victims have been reported to have retroposition of the maxilla (96), and morphometric analyses indicate that tongues of SIDS victims are heavier, wider, and thicker than control infants, unrelated to differences in fluid content (97). These differences were postulated to be genetic and to have developed prenatal because tongue weight was already increased in the youngest SIDS infants. Tongue weights were also significantly greater in males than in females.
Summary and Critique
Familial aggregation of obstructive sleep apnea syndrome, HLA abnormalities in affected men, and presence of deficient control of upper airway patency and hypoxic responsiveness in asymptomatic adult family members are all suggestive of genetic susceptibility factors. Because the relationship of ALTE to SIDS is unclear, however (15, 16), interpretation of analyses based on their combined frequency in these family cohorts is difficult. Among families with and without aggregation of obstructive sleep apnea syndrome, studies of nasopharyngeal airway dimensions are needed in SIDS victims and separately in ALTE patients. Pending a more defined relationship between SIDS and ALTE, population-based cohort studies need to be sufficiently large to analyze SIDS and ALTE rates as independent outcomes.
| |
PHYSIOLOGICAL STUDIES |
|---|
|
|
|---|
Siblings of a Previous SIDS Victim
Physiological studies in siblings of prior SIDS victims (SIDS siblings) are a potentially useful strategy to identify intermediate phenotypes relevant to SIDS (see "SIDS Pathophysiology") (Table 4). Thirty-one publications evaluate brain stem regulation of cardiorespiratory or other autonomic control systems in SIDS siblings and matched controls (98). Siblings were specifically identified as asymptomatic in half of the studies. In a study of control of breathing in SIDS siblings, one subject had a history of idiopathic ALTE (117), but the results were comparable to the asymptomatic siblings. Although health status is unknown in the remaining publications, clinical assessment usually began before symptoms related to ALTE would be likely. In 12 studies, for example, all SIDS siblings were younger than 1 mo of age.
|
Most siblings studied had only one prior sibling death from SIDS. A study of overnight cardiorespiratory recordings in 78 siblings included seven families with two SIDS and one family with three SIDS, but these eight siblings did not appear to have differences in apnea or bradycardia patterns compared with the other 70 siblings and siblings did not differ from controls (112). In the 11 publications derived from the same group of 35 subsequent siblings, infants with more than one prior SIDS sibling were excluded (99, 100, 102, 103, 105-107, 113- 116). Only 19 of 31 publications stated that the diagnosis of SIDS was confirmed by autopsy and only 13 of 19 specifically stated that the autopsy rate was 100%.
Brain stem abnormalities in respiratory control. Respiratory pattern was evaluated in nine studies. SIDS siblings were significantly more likely to have central and obstructive apnea and periodic breathing (98), and two other studies reported increased periodic breathing and more central apnea 5-14.9 s (108, 109). In another study, infants with a well-defined ALTE or family history of SIDS were divided into those with (a) family history of multiple SIDS, ALTE, or obstructive sleep apnea syndrome and (b) those without obstructive sleep apnea syndrome and only one SIDS or ALTE (129). Infants with a family history of multiple SIDS, ALTE, or obstructive sleep apnea syndrome were more likely to have mixed and obstructive apnea (p < 0.05) and these apneas occurred more frequently.
In contrast, SIDS siblings did not have an increased frequency of obstructive apnea in another study (107), and periodic breathing and central apnea frequency did not differ from control subjects in three other studies (110). In one study, the number of 2-5 s apneas at 3-4 mo of age, 6-9 s apneas at 1-6 mo of age, and apneas > 9 s during the first week of life were all actually significantly less in SIDS siblings compared with control subjects (103).
Ventilatory responses to hypercarbia or hypoxia were assessed in five publications (117). SIDS siblings had a normal ventilatory response to 4% CO2 but responded to mild hypoxia (17% O2) with decreased respiratory rate, increased total duration of apneas > 3 s, increased periodic breathing, and increased time spent in apnea compared with control subjects (117). Ventilatory response to hypercarbia was significantly less than control subjects in one study using the P0.1 occlusion technique (120), but another study found no diminished ventilatory response to 2-4% CO2 even though resting minute ventilation was significantly less than control subjects (119). There were no significant differences in the estimated ventilatory response to 2% CO2 or in resting transcutaneous PCO2 and PO2 (118). Older siblings of a previous SIDS had no apparent diminished ventilatory response to hypercarbia or hypoxia (121).
Arousal responses were reported in six publications and included analyses of both spontaneous electroencephalogram (EEG)-based and stimulus-based arousal responsiveness. SIDS siblings had significantly increased intervals between active sleep epochs at certain times during the night as newborns, and a reduced tendency to enter short waking periods at 2-3 mo of age compared with control subjects (113). The latter was interpreted as an increased tendency to remain asleep or a relative failure to arouse from sleep. A study of temporal patterning of slow-wave sleep (114) observed significantly increased delta amplitude in the early morning at 3-4 mo of age, consistent with higher arousal thresholds. SIDS siblings were significantly more likely to stay asleep longer and to proceed from AS to QS than to AW (115). Arousal responsiveness to partial nasal obstruction at 1 wk to 6 mo of age was significantly decreased during quiet sleep (122). At 3 mo, there was decreased movement associated with obstructive apnea (107). The number of SIDS siblings arousing to 4% CO2 was not decreased compared with control subjects, but there was a trend toward fewer arousals to 17% O2 (0 of 16 versus 3 of 13 in controls, p < 0.08) (117).
Increased brain stem auditory conduction times are indicative of delayed or deficient maturation of neural processing in
the brain stem (130, 131). Brain stem conduction times were
prolonged in 26 siblings compared with 67 control subjects
(123). Brain stem auditory evoked responses did not differ
from control subjects in another study, but only nine siblings
and 11 control subjects were studied (124). In a single study of
increased
-endorphin levels as a marker for diminished ventilatory drive in SIDS siblings,
-endorphin levels in spinal
fluid were significantly higher in SIDS siblings (127).
Other abnormalities in brain stem autonomic regulation. Sleep maturation has been assessed utilizing EEG power spectral analysis (116). Whereas abnormal sleep maturation might be associated with cardiorespiratory control abnormalities such as observed in some SIDS siblings, this study indicated accelerated sleep maturation compared with control subjects, resulting in a 1-mo advance in normal sequencing. They speculated that this acceleration might be a postnatal adaptive response to a stimulus such as hypoxia, but the actual stimulus is unknown and the clinical significance of this observation is hence also unknown.
Bradycardia and diminished heart rate variability have been implicated as autonomic abnormalities potentially associated with SIDS and tachycardia has been observed in infants later dying of SIDS (15, 16). During an overnight polysomnogram, heart rate was increased overall in SIDS siblings compared with control subjects (99), but fetal heart rate studied intrapartum or during home sleep recordings did not differ between the two groups (101, 102). SIDS siblings studied in utero at 36 wk gestation showed a trend toward more bradycardia > 10 min in duration (100). SIDS siblings have not been reported as having decreased heart rate variability, and the results have been similar to control subjects when studied postnatal (99, 101, 102). When studied in utero at 36 wk gestation, heart rate variability was increased (100), an observation of unknown clinical significance.
A prolonged Q-T interval (> 440-450 ms) has been implicated as a cause of SIDS (132). Among SIDS parents in whom at least one member had a prolonged Q-T interval, the Q-T interval was prolonged in 9 of 23 siblings of SIDS victims versus 0 of 18 siblings from the SIDS families with normal parental Q-T intervals (p < 0.01) (128). Although direct comparisons in siblings of prior SIDS victims with controls are needed, this study does indirectly support prolonged Q-T interval as one potential cause of SIDS and hence another genetic mechanism for SIDS (133).
Abnormalities in respiratory rate have not been associated with SIDS, except insofar as related to increased frequency or severity of apnea (15, 16). Although of uncertain clinical significance, the respiratory rate was increased in SIDS siblings in two studies (103, 105). In other studies, however, the respiratory rate was either lower than control subjects (104) or was similar (118).
Skin temperature in SIDS siblings was significantly increased during sleep, suggesting differences in temperature regulation (105). Although excessive sweating during sleep has been reported in SIDS victims, SIDS siblings do not have excessive sweating as determined by transepidermal water loss during sleep (125). Disordered autonomic function has also been hypothesized to be a mechanism for SIDS. When assessed by blood pressure and heart rate responses during sleep to postural change from supine to upright sitting, however, autonomic function was not different in SIDS siblings versus control subjects (126).
Parents of SIDS Victims
In addition to family studies of obstructive sleep apnea syndrome already discussed, these studies include ventilatory responses to hypercarbia and/or hypoxia (134) and sleep state regulation (100, 134) (Table 5). The autopsy rate was 100% in seven studies (100, 134) and not mentioned in one (140). Two studies specified inclusion of only families with a single SIDS (137, 138). One negative study of ventilatory chemosensitivity included two fathers with two SIDS children each (139), and one study showing reduced ventilatory response to hypoxia included a couple with two SIDS children (140). Mothers of two infant SIDS victims (80) had significantly fewer siblings than did their husbands and the parents of a single SIDS (p < 0.001).
Brain stem abnormalities in respiratory control. There was a trend toward diminished ventilatory responses to 5% CO2 in SIDS parents (135). In response to 4% CO2, however, there were no changes in respiratory rate, tidal volume, inspiratory time, arterial blood gases, or ventilation compared with control subjects (136). Using a single vital capacity breath of 13% CO2, parents did not differ from control subjects in regard to tidal or minute volume, tidal volume/inspiratory time, or inspiratory time/respiratory cycle time (137).
Measuring ventilatory responses to hypercarbia or hypoxia using increased airway resistance may be a more sensitive test for detecting differences between SIDS parents and control subjects. In two studies of ventilatory responsiveness to 5-7% CO2 with inspiratory loading, lower ventilatory drive was observed in parents of SIDS, with and without inspiratory flow resistance (138). At a lower inspiratory flow resistance, however, the response to hypercarbia was not decreased (139).
Ventilatory responsiveness to hypoxia was studied in four reports. One study documented a lower ventilatory response to progressive isocapnic hypoxia in parents of SIDS (expired PO2 = 50 mm Hg) (140). Three other studies (134, 136, 139), however, observed no difference in responsiveness even though the hypoxic stimulus was greater (expired PO2 = 40 mm Hg).
Sleep. Sleep state regulation and breathing control regulation are closely related. Mothers of SIDS victims studied at 36 wk gestation during the next pregnancy had less REM sleep and decreased Stage IV quiet sleep than control subjects (100), but the clinical significance of this difference is unclear. In fathers and nonpregnant mothers, there were no differences in sleep characteristics (134).
Summary and Critique
The physiological studies in siblings of prior SIDS victims and parents of SIDS investigate multiple putative cardiorespiratory control and other brain stem autonomic abnormalities related to SIDS. Approximately half of the studies in SIDS siblings and a somewhat lesser percentage in parents of SIDS identified abnormalities. Although no contradictory results were observed in parental studies, fetal heart rate variability was increased in siblings of prior SIDS whereas it is decreased in infants later dying of SIDS (15). One study of apnea and periodic breathing reported fewer rather than more apnea at some ages, but these overnight recordings were performed in a sleep laboratory rather than at home and the results may not be interchangeable.
Deficient arousal responsiveness was the most consistent abnormality in SIDS siblings and the most compelling in regard to increased mortality risk (27,55). Unfortunately, arousal responsiveness has not been studied in parents of SIDS. Generalizability of these arousal response deficits is enhanced by the consistency of results despite using three different assessment strategies in three separate subject groups at multiple ages.
Some of the results in siblings and parents of prior SIDS, including obstructive sleep apnea cohorts, are consistent with incomplete phenotypes having increased susceptibility to SIDS. Most of the negative physiological studies were small, and power to detect a significant difference was likely insufficient considering the high intragroup variability. It is possible that larger study populations might have identified a broader scope of brain stem autonomic deficits. A meta-analysis of these multiple small studies was not performed due to the general lack of standardization in methodology and analysis.
Other limitations in the physiologic studies may also be pertinent. First, 11 of the studies in SIDS siblings were based on a single group of about 35 siblings (99, 100, 102, 103, 105, 113) who may not be representative of all subsequent siblings. Second, most of the other sibling studies of apnea did not utilize breath-detection methods capable of identifying obstructed breaths and included few if any extreme apnea/bradycardia events most likely to be of clinical significance (Table 4) (141). Third, no information is available regarding presence of epidemiological risk factors that might contribute to the differences observed. Fourth, many of the studies do not specify the extent to which analyses were conducted blind to group identity of the subjects. Fifth, we cannot exclude the possibility that cause of death in some of the index siblings was intentional suffocation rather than SIDS and that some of the siblings of presumed SIDS were intentionally being intermittently suffocated to cause the observed physiological differences. Inclusion of cases of intentional suffocation misdiagnosed as SIDS, however, would not explain the differences observed in parental studies, and would not explain some of the differences observed in the sibling studies, especially at the youngest ages. These limitations notwithstanding, the physiological data are in the aggregate consistent with the hypothesis that deficiencies in cardiorespiratory control and arousal from sleep are present in some SIDS siblings and may contribute to increased susceptibility to SIDS in these families.
| |
IMPLICATIONS |
|---|
|
|
|---|
Studies indicate multiple genetic influences on developmental maturation of brain stem autonomic control mechanisms including cardiorespiratory control and arousal (Table 6). To the extent that phenotypes with impairment in such mechanisms are indeed at increased risk for SIDS, genetic susceptibility is most likely related, as in other complex conditions, to polygenic abnormalities with incomplete penetrance (63). Susceptibility conferred by alleles at one locus would hence also depend on alleles at other independently segregating loci interacting with environmental influences. Polygenic susceptibility to recurrent infant mortality notwithstanding, therefore, genetic susceptibility may be most relevant when confronted with sufficient environmental influence(s).
There have been multiple barriers to acceptance of a genetic role in pathophysiology of SIDS. These barriers have included a desire to minimize potential for parental guilt or blame and the misperception that acknowledging a genetic role implies a single gene disease or existence of discrete genotypes causing SIDS unrelated to environmental risks. Another barrier has been an assumption that SIDS does not adhere to usual patterns of disease associated with other natural causes of infant mortality in which genetic and environmental interactions are well accepted. To the extent that some cases of SIDS are associated with cardiorespiratory, arousal, or other autonomic deficits, our increasing knowledge of related genetic mechanisms suggests that the question is no longer whether there is a genetic defect but rather "how strong is the genetic component and what genes are involved?" (142).
There are no new strategies for "diagnosing" intentional suffocation and quantifying its contribution to sudden unexpected infant mortality. It is therefore impossible to calculate extent of familial aggregation of SIDS using measures such as the recurrence risk ratio (143). Failure to diagnose infant suffocation, however, does not explain the increased mortality rate in subsequent siblings from explained natural causes or the physiological abnormalities observed in some parents of SIDS, and likely does not explain the physiological abnormalities observed in younger siblings of SIDS. Although no studies reviewed exclude substantial environmental influences, these studies document increased recurrent mortality rates in subsequent siblings from explained natural causes.
A major potential impact of these hypothesized links among genetic susceptibility, SIDS, and recurrent infant mortality in siblings may be inclusion of genetic susceptibility in future explorations of mechanisms for SIDS and relationship to other clinical entities (142). Notwithstanding the evidence for recurrent SIDS in siblings of SIDS victims, recurrent SIDS is nevertheless an uncommon occurrence. Assuming an incidence of SIDS of 0.7 deaths/1,000 live births for the first sibling and RR = 5 for recurrence, SIDS parents considering another pregnancy can be reassured that depending on magnitude of environmental risk factors, 99.65% or more of siblings may survive infancy.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Carl E. Hunt, Director, National Center on Sleep Disorders Research, National Heart, Lung, and Blood Institute, Two Rockledge Centre, Room 10038, 6701 Rockledge Drive, MSC 7920, Bethesda, MD 20892-7920. E-mail: huntc{at}nhlbi.nih.gov
(Received in original form October 13, 2000 and in revised form January 5, 2001).
Acknowledgments:
The author wishes to thank Marian Willinger, Ph.D. (Special Assistant for SIDS, Pregnancy and Perinatology Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD) and George
Lister, M.D. (Professor of Pediatrics, Yale University School of Medicine,
New Haven, CT) for their critical review of this manuscript.
| |
References |
|---|
|
|
|---|
1. Firstman R, Talan J. The death of innocents. New York: Bantam Books; 1997.
2. Hickey C, Lighty T, O'Brien J. Goodbye, my little ones. New York: Penguin Books USA Inc; 1996.
3. Lucey JF. Why all pediatricians should read this book. Pediatrics 1997; 100: A77 .
4. Platt MW, Blair PS, Fleming PJ, Smith IJ, Cole TJ, Leach CEA, Berry PJ, Golding J. the CESDI SUDI Research Group. A clinical comparison of SIDS and explained sudden infant deaths: how healthy and how normal? Arch Dis Child 2000; 82: 90-106 .
5. Cote A, Russo P, Michaud J. Sudden unexpected deaths in infancy: what are the causes? J Pediatr 1999; 135: 437-443 [Medline].
6.
Reece RM.
Fatal child abuse and sudden infant death syndrome: a critical diagnostic decision.
Pediatr
1993;
91:
423-429
7.
Krugman RD,
Bays JA,
Chadwick DL,
Kanda MB,
Levitt CJ,
McHugh MT.
Distinguishing sudden infant death syndrome from
child abuse fatalities.
Pediatrics
1994;
94:
124-126
8.
Wissow LS.
Child abuse and neglect.
N Engl J Med
1995;
332:
1425-1431
9.
Duhaime A-C,
Christian CW,
Rorke LB,
Zimmerman RA.
Nonaccidental head injury in infants
The "shaken-baby syndrome."
N Engl
J Med
1998;
338:
1822-1829
10. David TJ. Shaken baby (shaken impact) syndrome: non-accidental head injury in infancy. J R Soc Med 1999; 92: 556-561 [Medline].
11. Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol 1991; 11: 677 [Medline].
12.
Guyer B,
Hoyert DL,
Martin JA,
Ventura SJ,
MacDorman MF,
Strobino DM.
Annual summary of vital statistics
1998.
Pediatrics
1999;
104:
1229-1246
13. Valdes-Dapena M. The sudden infant death syndrome: pathologic findings. Clin Perinatol 1992; 19: 701-716 [Medline].
14. Mitchell EA, Becroft DMO. SIDS. . .an adequate cause of death? Acta Pediatr 1998; 87: 1217-1218 [Medline].
15. Hunt CE. The cardiorespiratory control hypothesis for sudden infant death syndrome. Clin Perinatol 1992; 19: 757-771 [Medline].
16. Hunt CE. Sudden infant death syndrome. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics, 16th ed. Philadelphia: W.B. Saunders Company; 2000.
17. Panigrahy A, Filiano JJ, Sleeper LA, Mandell F, Valdes-Depena M, Krous HF, Rava LA, White WF, Kinney HC. Decreased kainate receptor binding in the arcuate nucleus of the sudden infant death syndrome. J Neurophysiol Exp Neurol 1997; 56: 1253-1261 .
18. Harper RM, Kinney HC, Fleming PJ, Thach BT. Sleep influences on homeostatic functions: implications for sudden infant death syndrome. Respir Physiol 2000; 119: 123-132 [Medline].
19. Kinney HC, Panigrahy A, Filiano JJ, Sleeper LA, White WF. Brain stem serotonergic receptor binding in the sudden infant death syndrome. J Neuropathol Exp Neurol 2000; 59: 377-384 [Medline].
20. Blackwell CC, Weir DM, Busuttil A. Infection, inflammation and sleep: more pieces to the puzzle of sudden infant death syndrome (SIDS). APMIS 1999; 107: 455-473 [Medline].
21. Opdal SH, Vege A, Stave AK, Rognum TO. The complement component C4 in sudden infant death. Eur J Pediatr 158:210-212.
22. Platt MS, Yunginger JW, Secula-Periman A, Irani AMA, Smialek J, Mirachandani HG, Schwartz LB. Involvement of mast cells in sudden infant death syndrome. J Allergy Clin Immunol 1994; 94: 250-256 [Medline].
23. Holgate ST, Walters C, Walls AF, Lawrence S, Shell DJ. The anaphylaxis hypothesis of sudden infant death syndrome (SIDS): mast cell degranulation in cot death revealed by elevated concentrations of tryptase in serum. Clin Exp Allergy 1994; 24: 1115-1122 [Medline].
24. Gold Y, Goldberg A, Sivan Y. Hyper-releasability of mast cells in family members of infants with sudden infant death syndrome and apparent life-threatening events. J Pediatr 2000; 136: 460-465 [Medline].
25. Eisenberg L. Conference Summary: The implications of genetics for health professional education. Hager M, editor. New York: Josiah Macy, Jr. Foundation; 1999.
26. Fortin G, Dominguez del Toro E, Abadie V, Guimaraes L, Foutz AS, Denavit-Saubie M, Rouyer F, Champagnat J. Genetic and developmental models for the neural control of breathing in vertebrates. Respir Physiol 2000; 122: 247-257 [Medline].
27. Kahn A, Franco P, Scaillet S, Groswasser J, Dan B. Development of cardiopulmonary integration and the role of arousability from sleep. Curr Opinion Pulmon Med 1997; 3: 440-444 . [Medline]
28. Schibler U, Tafti M. Molecular approaches towards the isolation of sleep-related genes. J Sleep Res 1999;8(Suppl 1):1-10.
29. Tafti M, Chollet D, Valatx JL, Franken P. Quantitative trait loci approach to the genetics of sleep in recombinant inbred mice. J Sleep Res 1999;8(Suppl 1):37-43.
30. Katz DM, Balkowiec A. New insights into the ontogeny of breathing from genetically engineered mice. Curr Opinion Pulmon Med 1997; 3: 433-439 . [Medline]
31.
Erickson JT,
Conover JC,
Borday V,
Champagnat J,
Barbacid M,
Yancopoulos G,
Katz DM.
Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking
NT4 and display a severe developmental deficit in control of breathing.
J Neurosci
1996;
16:
5361-5371
32. Jacquin TD, Borday V, Schneider-Maunoury S, Topilko P, Ghilini G, Kato F, Charmay P, Champagnat J. Reorganization of pontine rhythmogenic neuronal networks in Krox-20 knockout mice. Neuron 1996; 17: 747-758 [Medline].
33. Burton MD, Kawashima A, Brayer JA, Kazemi H, Shannon DC, Schuchardt A, Costantini F, Pachnis V, Kinane TB. RET proto-oncogene is important for the development of respiratory CO2 sensitivity. J Auto Nerv Syst 1997; 63: 137-143 . [Medline]
34. Dauger S, Renolleau S, Vardon G, Nepote V, Mas C, Simonneau M, Gaultier C, Gallego J. Ventilatory responses to hypercapnea and hypoxia in Mash-1 heterozygous newborn and adult mice. Pediatr Res 1999; 46: 535-542 [Medline].
35. Hirsch MR, Tiveron MC, Guillemot F, Brunet JF, Goridis C. Control of noradrenergic differentiation and Phox2a expression in Mash-1 in the central and peripheral nervous system. Development 1998; 125: 599-608 [Abstract].
36. Hoffman HJ, Hillman LS. Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postneonatal risk factors. Clin Perinatol 1992; 19: 717-737 [Medline].
37. Leach CEA, Blair PS, Fleming PJ, Smith IJ, Platt MW, Berry PJ, Golding J, the CESDI SUDI Research Group. Epidemiology of SIDS and explained sudden infant deaths. Pediatrics 1999;104:4/e43.
38.
Katwinkel J,
Brooks JG,
Keenan ME,
Malloy M.
American Academy
of Pediatrics: Changing concepts of sudden infant death syndrome:
implications for infant sleeping environment and sleep position.
Pediatrics
2000;
105:
650-656
39.
Khoury MJ,
Beaty TH,
Liang K-L.
Can familial aggregation of disease
be explained by familial aggregation of environmental risk factors.
Am J Epidemiol
1988;
127:
674-683
40.
Lie RT,
Wilcox AJ,
Skjaerven R.
A population based study of the risk
of recurrence of birth defects.
N Engl J Med
1994;
331:
1-4
41.
Skjaerven R,
Wilcox AJ,
Lie RT.
A population-based study of survival
and childbearing among female subjects with birth defects and the
risk of recurrence in their children.
N Engl J Med
1999;
340:
1057-1062
42. Barnes KC. Genetics and bronchial asthma: what is new? Pediatr Pulmonol 1997; 16: 80-81 .
43.
Sandford AJ,
Pare PD.
The genetics of asthma.
Am J Respir Crit Care
Med
2000;
161:
S202-S206
44.
Fryer AA,
Bianco A,
Hepple M,
Jones PW,
Strange RC,
Spiteri MA.
Polymorphism at the glutathione 5-transferase GSTP1 locus.
Am J
Respir Crit Care Med
2000;
161:
1437-1442
45.
Palmer LJ,
Burton PR,
Faux JA,
James AL,
Musk W,
Cookson WOCM.
Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness.
Am J Respir Crit Care Med
2000;
161:
1836-1843
46.
Hoover RN.
Cancer
Nature, nurture, or both.
N Engl J Med
2000;
343:
135-136
47.
Knopp RH.
Drug treatment of lipid disorders.
N Engl J Med
1999;
341:
498-511
48.
Botto LD,
Moore CA,
Khoury MJ,
Erickson JD.
Neural-tube defects.
N Engl J Med
1999;
341:
1509-1519
49.
Casselbrant ML,
Mandel EM,
Fall PA,
Rockette HE,
Kurs-Lasky M,
Bluestone CD,
Ferrell RE.
The heritability of otitis media: a twin
and triplet study.
JAMA
1999;
282:
2125-2130
50.
Ehrlich GD,
Post JC.
Susceptibility to otitis media: strong evidence that
genetics plays a role.
JAMA
1999;
282:
2167-2169
51. Rosaratnam I, Ryan PFJ. Systemic lupus erythematosus (SLE): changing concepts and challenges for the new millennium. Aust NZ J Med 1998; 28: 5-11 [Medline].
52.
Kohler HP,
Grant PJ.
Plasminogen-activator inhibitor type 1 and coronary artery disease.
N Engl J Med
2000;
342:
1792-1801
53.
Hammond CJ,
Snieder H,
Spector TD,
Gilbert CE.
Genetic and environmental factors in age-related nuclear cataracts in monozygotic
and dizygotic twins.
N Engl J Med
2000;
342:
1786-1790
54.
Sveinbjornsdottir S,
Hicks AA,
Jonsson T,
Petursson H,
Guomundsson G,
Frigge ML,
Kong A,
Gulcher JR,
Stefansson K.
Familila aggregation of Parkinson's disease in Iceland.
N Engl J Med
2000;
343:
1765-1770
55. Hunt CE. Prone sleeping in healthy infants and SIDS victims. J Pediatr 1996; 98: 594-596 .
56. Waters KA, Gonzalez AJC, Morielli A, Brouillette RT. Face-straight-down and face-near-straight-down positions in healthy, prone-sleeping infants. J Pediatr 1996; 128: 616-625 [Medline].
57. Chiodini BA, Thach BT. Impaired ventilation in infants sleeping facedown: potential significance for sudden infant death syndrome. J Pediatr 1993; 123: 686-692 [Medline].
58. Patel AL, Harris K, Thach BT. Hypoxemia in a rebreathing environment: relevance for mechanism of sudden infant death syndrome (SIDS). Pediatr Res 2000;47(Part 2):480A.
59.
Carolan PL,
Wheeler WB,
Ross JD,
Kemp JS.
Potential to prevent carbon dioxide rebreathing of commercial products marketed to reduce
sudden infant death syndrome risk.
Pediatrics
2000;
105:
774-779
60. Tuffnell CS, Peterson SA, Wailoo MP. Prone sleeping infants have a reduced ability to lose heat. Early Hum Devel 1995; 43: 109-116 . [Medline]
61. Milrad J, Walsh WF. Nicotine attenuates the ventilatory response to hypoxia in the developing lamb. Pediatr Res 1995; 37: 652-660 [Medline].
62. Hasan SU, Simakajornboon N, MacKinnon Y, Goxal D. Antenatal cigarette smoke exposure induces selective changes in expression of protein kinase C (PKC) isoforms within the dorsocaudal brain stem of the neonatal rat. Pediatr Res 2000; 47: 360A .
63.
Holtzman NA,
Marteau TM.
Will genetics revolutionize medicine?
N
Engl J Med
2000;
343:
141-144
64. Lewis KW, Bosque EM. Deficient hypoxia awakening response in infants of smoking mothers. J Pediatr 1995; 127: 691-699 [Medline].
65. Hafstrom O, Milerad J, Asokan N, Poole SD, Sundell HW. Nicotine delays arousal during hypoxemia in lambs. Pediatr Res 2000; 47: 646-652 [Medline].
66. Ueda Y, Stick SM, Hall G, Sly PD. Control of breathing in infants born to smoking mothers. J Pediatr 1999; 135: 226-232 [Medline].
67. Franco P, Groswasser J, Hassid S, Lanquart JP, Scaillet S, Kahn A. Prenatal exposure to cigarette smoking is associated with a decrease in arousal in infants. J Pediatr 1999; 135: 34-38 [Medline].
68. Froen JF, Akre H, Stray-Pedersen B, Saugstad OD. Adverse effects of nicotine and interleukin-1B on autoresuscitation after apnea in piglets: implications for sudden infant death syndrome. Pediatrics 2000; 105:4/e52.
69. Yukawa N, Carter N, Rutty G, Green MA. Intra-alveolar haemorrhage in sudden infant death syndrome: a cause for concern? J Clin Pathol 1999; 52: 581-587 [Abstract].
70. Berry PJ. Intra-alveolar haemorrhage in sudden infant death syndrome: a cause for concern? J Clin Pathol 1999; 52: 553-554 [Medline].
71.
Davis P,
McClure RJ,
Rolfe K,
Chessman N,
Pearson S,
Sibert JR,
Meadow R.
Procedures, placement, and risk of further abuse after
Münchausen syndrome by proxy, non-accidental poisoning, and non-accidental suffocation.
Arch Dis Child
1998;
78:
217-221
72.
Donald T,
Jureidini J.
Münchausen syndrome by proxy.
Arch Pediatr
Adolesc Med
1996;
150:
753-758
73.
Hall DE,
Eubanks L,
Meyyazhagan S,
Kenney RD,
Johnson SC.
Evaluation of covert video surveillance in the diagnosis of Münchausen syndrome by proxy: Lessons from 41 cases.
Pediatrics
2000;
105:
1305-1312
74.
Southall DP,
Plunkett MCB,
Banks MW,
Falkov AF,
Samuels MP.
Covert video records of life-threatening child abuse: Lessons for child
protection.
Pediatrics
1997;
100:
735-760
75. Wolkind S, Taylor EM, Waite AJ, Dalton M, Emery JL. Recurrence of unexpected infant death. Acta Paediatr 1993; 82: 873-876 [Medline].
76.
Oyen N,
Skjaerven R,
Irgens LM.
Population-based recurrence risk of
sudden infant death syndrome compared with other infant and fetal
deaths.
Am J Epidemiol
1996;
144:
300-305
77. Guntheroth WG, Lohmann R, Spiers PS. Risk of sudden infant death syndrome in subsequent siblings. J Pediatr 1990; 116: 520-524 [Medline].
78.
Adams MM,
Elam-Evans LD,
Wilson HG,
Gilbertz DA.
Rates of and
factors associated with recurrence of preterm delivery.
JAMA
2000;
283:
1591-1596
79. Froggatt P, Lynas MA, MacKenzie G. Epidemiology of sudden unexpected death in infants ("cot death") in Northern Ireland. Br J Prev Soc Med 1971; 25: 119-134 [Medline].
80. Peterson DR, Chinn NM, Fisher LD. The sudden infant death syndrome: repetitions in families. J Pediatr 1980; 97: 265-268 [Medline].
81. Peterson DR, Sabotta EE, Daling JR. Infant mortality among subsequent siblings of infants who died of sudden infant death syndrome. J Pediatr 1986; 108: 911-914 [Medline].
82. Irgens LM, Skjaerven R, Peterson DR. Prospective assessment of recurrence risk in sudden infant death syndrome siblings. J Pediatr 1984; 104: 349-351 [Medline].
83.
Beal SM,
Blundell HK.
Recurrence incidence of sudden infant death
syndrome.
Arch Dis Child
1988;
63:
924-930
84. Beal SM. Sudden infant death syndrome in twins. Pediatrics 1989;84; 1038-1044.
85.
Malloy MH,
Freeman DH.
Sudden infant death syndrome among twins.
Arch Pediatr Adolesc Med
1999;
153:
736-740
86.
Kohlendorfer U,
Kiechl S,
Sperl W.
Sudden infant death syndrome:
risk factor profiles for distinct subgroups.
Am J Epidemiol
1998;
147:
960-968
87.
Lesko SM,
Corwin MJ,
Vezina RM,
Hunt CE,
Mandell F,
McClain M,
Heeren T,
Mitchell AA.
Changes in sleep position during infancy: a
prospective longitudinal assessment.
JAMA
1998;
280:
336-340
88. Pillar G, Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151: 688-691 [Abstract].
89. Pillar G, Schnall RP, Peled N, Oliven, Lavie P. Impaired respiratory response to resistive loading during sleep in healthy offspring of patients with obstructive sleep apnea. Am J Respir Crit Care Med 1997; 155:1602-1608.
90. Redline S, Tishler PV, Tosteson TD, Williamson J, Kump K, Browner I, Ferrette V, Krejci P. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 1682-1687 [Abstract].
91.
Redline S,
Leitner J,
Arnold J,
Tishler PV,
Altose MD.
Ventilatory-control abnormalities in familial sleep apnea.
Am J Respir Crit Care
Med
1997;
156:
155-160
92. Tishler PV, Redline S, Ferrette V, Hans MG. The association of sudden unexpected infant death with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 153: 1857-1863 [Abstract].
93.
Guilleminault C,
Partinen M,
Hollman K,
Powell N,
Stoohs R.
Familial
aggregates in obstructive sleep apnea syndrome.
Chest
1996;
107:
1545-1551
94. Yoshizawa T, Akashiba T, Kurashina K, Otsuka K, Horie T. Genetics and obstructive sleep apnea syndrome: a study of human leukocyte antigen (HLA) typing. Intern Med 1993; 32: 94-97 [Medline].
95. Kushida C, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med 1997; 127: 581-587 .
96.
Rees K,
Wright A,
Keeling JW,
Douglas NJ.
Facial structure in the sudden infant death syndrome.
BMJ
1998;
317:
179-180
97. Siebert JR, Haas JE. Enlargement of the tongue in sudden infant death syndrome. Pediatr Pathol 1991; 11: 813-826 [Medline].
98. Kahn A, Blum D, Montauk L. Polysomnographic studies and home monitoring of siblings of SIDS victims and of infants with no family history of sudden infant death. Eur J Pediatr 1986; 145: 351-356 [Medline].
99. Harper RM, Leake B, Hoppenbrouers T, Sterman MB, McGinty DJ, Hodgman J. Polygraphic studies of normal infants and infants at risk for the sudden infant death syndrome: heart rate and variability as a function of state. Pediatr Res 1978; 12: 778-785 [Medline].
100. Hoppenbrouwers T, Hodgman JE, Harper RM, Sterman MB. Fetal heart rates in siblings of infants with sudden infant death syndrome. Obstet Gynecol 1981; 58: 319-325 [Medline].
101. Peirano P, Lacombe J, Kastler B, Guillon G, Vicente G, Monod N. Night sleep heart rate patterns recorded by cardioneumography at home in normal and at-risk for SIDS infants. Early Hum Dev 1988; 17: 175-186 [Medline].
102. Hoppenbrouwers T, Zanini B, Hodgman JE. Intrapartum fetal heart rate and sudden infant death syndrome. Am J Obstet Gynecol 1979; 133: 217-220 [Medline].
103.
Hoppenbrouwers T,
Hodgman JE,
McGinty DJ,
Harper RM,
Sterman MB.
Sudden infant death syndrome: sleep apnea and respiration in
subsequent siblings.
Pediatrics
1980;
66:
205-214
104. Curzi-Dascalova L, Flores-Guevara R, Guidasci S, Korn G, Monod N. Respiratory frequency during sleep in siblings of sudden infant death syndrome victims: a comparison with control, normal infants. Early Hum Dev 1983; 8: 235-241 [Medline].
105. Hoppenbrouwers T, Hodgman JE. Skin temperatures and respiratory rates in subsequent siblings of infants who died of sudden infant death syndrome (SIDS). IEEE Eng Med Biol 1992; 14: 2616-2617 .
106. Hoppenbrouwers T, Jensen DK, Hodgman JE, Harper RM, Sterman MB. The emergence of a circadian pattern in respiratory rates: comparison between control infants and subsequent siblings of SIDS. Pediatr Res 1980; 14: 345-351 [Medline].
107. Hoppenbrouwers T, Hodgman JE, Cabal L. Obstructive apnea, associated patterns of movement, heart rate, and oxygenation in infants at low and increased risk for SIDS. Pediatr Pulmonol 1993; 15: 1-12 [Medline].
108.
Kelly DH,
Walker AM,
Cahen L,
Shannon DC.
Periodic breathing in
siblings of sudden infant death syndrome victims.
Pediatrics
1980;
66:
515-520
109.
Kelly DH,
Twanmoh J,
Shannon DC.
Incidence of apnea in siblings of
sudden infant death syndrome victims studied at home.
Pediatrics
1982;
70:
128-131
110. Flores-Guevara R, Sternberg B, Peirano P, Guidasci S, Durupt N, Monod N. Respiratory pauses and periodic breathing assessed by cardiopneumography in normal infants and in SIDS siblings. Neuropediatrics 1986; 17: 59-62 [Medline].
111.
Keens TG,
Ward SL,
Gates EP,
Andree DI,
Hart LD.
Ventilatory pattern following diphtheria-tetanus-pertussis immunization in infants
at risk for sudden infant death syndrome.
Am J Dis Child
1985;
139:
991-994
112.
Southall DP,
Alexander JR,
Stebbens VA,
Taylor VG.
Cardiorespiratory patterns in siblings of babies with sudden infant death syndrome.
Arch Dis Child
1987;
62:
721-726
113.
Harper RM,
Leake B,
Hoffman H,
Walter DO,
Hoppenbrouwers T,
Hodgman J,
Sterman MB.
Periodicity of sleep states is altered in
infants at risk for the sudden infant death syndrome.
Science
1981;
213:
1030-1032
114. Schechtman VL, Harper RK, Harper RM. Aberrant temporal patterning of slow-wave sleep in siblings of SIDS victims. Electroencephalogr Clin Neurophysiol 1995; 94: 95-102 [Medline].
115. Hoppenbrouwers T, Hodgman JE, Arakawa K, Sterman MB. Polysomnographic sleep and waking states are similar in subsequent siblings of SIDS and control infants during the first six months of life. Sleep 1989; 12: 265-276 [Medline].
116. Sterman MB, McGinty DJ, Harper RM, Hoppenbrouwers T, Hodgman JE. Developmental comparison of sleep EEG power spectral patterns in infants at low and high risk for sudden death. Electroencephalogr Clin Neurophysiol 1982; 53: 166-181 [Medline].
117. Brady JP, McCann EM. Control of ventilation in subsequent siblings of victims of sudden infant death syndrome. J Pediatr 1985; 106: 212-217 [Medline].
118.
Schafer T,
Schafer D,
Schlafke ME.
Breathing, transcutaneous blood
gases, and CO2 response in SIDS siblings and control infants during
sleep.
J Appl Physiol
1993;
74:
88-102
119. Coleman JM, Mammel MC, Reardon C, Boros SJ. Hypercarbic ventilatory responses of infants at risk for SIDS. Pediatr Pulmonol 1987; 3: 226-230 [Medline].
120.
Parks YA,
Paton JY,
Beardsmore CS,
MacFadyen UM,
Thompson J,
Goodenough PC,
Simpson H.
Respiratory control in infants at increased risk for sudden infant death syndrome.
Arch Dis Child
1989;
64:
791-797
121. Glomb WB, Marcus CL, Keens TG, Davidson Ward SL. Hypercarbic and hypoxic ventilatory responses in school-aged siblings of sudden infant death syndrome victims. J Pediatrics 1992;121:391-397.
122. Neuman NM, Frost JK, Bury L, Jordan K, Phillips K. Responses to partial nasal obstruction in sleeping infants. Aust Paediatr J 1986; 22: 111-116 [Medline].
123. Pettigrew AG, Rahilly PM. Brain stem auditory evoked responses in infants at risk of sudden infant death. Early Hum Dev 1985; 11: 99-111 [Medline].
124. Kileny P, Finer N, Sussman P, Schopflocher D. Auditory brain stem responses in sudden infant death syndrome: comparisons of siblings, "near-miss," and normal infants. J Pediatr 1982; 101: 225-227 [Medline].
125.
Kahn A,
Van de Merckt C,
Dramaix M,
Magrez P,
Fellow FNRS,
Blum D,
Rebuffat E,
Montauk L.
Transepidermal water loss during sleep
in infants at risk for sudden death.
Pediatrics
1987;
80:
245-250
126. Fox GPP, Matthews TG. Autonomic dysfunction at different ambient temperatures in infants at risk of sudden infant death syndrome. Lancet 1989; 74: 1065-1067 .
127. Myer EC, Morris DL, Adams ML, Brase DA, Dewey WL. Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome. J Pediatr 1987; 111: 660-666 [Medline].
128.
Maron BJ,
Clark CE,
Goldstein RE,
Epstein SE.
Potential role of QT
interval prolongation in sudden infant death syndrome.
Circulation
1976;
54:
423-430
129. McNamara F, Sullivan CE. Obstructive sleep apnea in infants: relation to family history of sudden infant death syndrome, apparent life-threatening events, and obstructive sleep apnea. J Pediatr 2000; 136: 318-323 [Medline].
130. Henderson-Smart DJ, Pettigrew AG, Campbell DJ. Clinical apnea and brain-stem neural function in preterm infants. N Engl J Med 1983; 308: 353-357 [Abstract].
131.
Beckerman R,
Meltzer J,
Sola A,
Dunn D,
Wegmann M.
Brain-stem
auditory response in Ondine's syndrome.
Arch Neurol
1986;
43:
698-701
132.
Schwartz PJ,
Stramba-Badiale M,
Segantini A,
Austoni P,
Bosi G,
Giorgetti R,
Grancini F,
Marni ED,
Perticone F,
Rosti D,
Salice P.
Prolongation of the QT interval and the sudden infant death syndrome.
N Engl J Med
1998;
338:
1709-1714
133.
Schwartz PJ,
Priori SG,
Dumaine R,
Napolitano C,
Antzelevitch C,
Stramba-Badiale M,
Richard TA,
Berti MR,
Bloise R.
A molecular
link between the sudden infant death syndrome and the long-QT
syndrome.
N Engl J Med
2000;
343:
262-267
134. Acres JC, Sweatman P, West P, Brownell L, Kryger MH. Breathing during sleep in parents of sudden infant death syndrome victims. Am Rev Respir Dis 1982; 125: 163-166 [Medline].
135.
Berman TM,
Bartlett M,
Westgate HD,
Steiner KR,
Kronenberg RS.
Attenuated responses to CO2 and hypoxia in parents of threatened
sudden infant death syndrome infants.
Chest
1981;
79:
536-539
136. Zwillich C, McCullough R, Guilleminault C, Cummiskey J, Weil JV. Respiratory control in the parents of sudden infant death syndrome victims: ventilatory control in SIDS parents. Pediatr Res 1980; 14: 762-764 [Medline].
137.
Couriel JM,
Olinsky A.
Response to acute hypercapnia in the parents
of victims of sudden infant death syndrome.
Pediatrics
1984;
73:
652-655
138. Schiffman PL, Westlake RE, Santiago TV, Edelman NH. Ventilatory control in parents of victims of sudden infant death syndrome. N Engl J Med 1980; 302: 486-491 [Abstract].
139. Lewis NC, McBride JT, Brooks JG. Ventilatory chemosensitivity in parents of infants with sudden infant death syndrome. J Pediatr 1988; 113: 307-311 [Medline].
140. Schiffman PL, Remolina C, Westlake RE, Santiago TV, Edelman NH. Ventilatory response to isocapnic hypoxia in parents of victims of sudden infant death syndrome. Chest 1982; 81: 707-710 [Abstract].
141.
Ramanathan R,
Corwin MJ,
Hunt CE, et al
.
and the CHIME Study
Group. Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS.
JAMA
2001;
285:
2199-2207
142. Han F, Strohl KP. Inheritance of ventilatory behavior in rodent models. Respir Physiol 2000; 121: 247-256 [Medline].
143. Risch N. Linkage strategies for genetically complex traits: I. Multilocus models. Am J Hum Genet 1990; 46: 222-228 [Medline].
This article has been cited by other articles:
![]() |
M J Campbell, D Hall, T Stephenson, C Bacon, and J Madan Recurrence rates for sudden infant death syndrome (SIDS): the importance of risk stratification Arch. Dis. Child., November 1, 2008; 93(11): 936 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
C J Bacon, D B M Hall, T J Stephenson, and M J Campbell How common is repeat sudden infant death syndrome? Arch. Dis. Child., April 1, 2008; 93(4): 323 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M Eisenstein, Z. Haklai, S. Schwartz, A. Klar, N. Stein, and E. Kerem Investigation of unexplained infant deaths in Jerusalem, Israel 1996-2003 Arch. Dis. Child., August 1, 2007; 92(8): 697 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Hunt and F. R. Hauck Sudden infant death syndrome. Can. Med. Assoc. J., June 20, 2006; 174(13): 1861 - 1869. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Chadwick, H. F. Krous, and D. K. Runyan Meadow, Southall, and the General Medical Council of the United kingdom. Pediatrics, June 1, 2006; 117(6): 2247 - 2251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C E Hunt Gene-environment interactions: implications for sudden unexpected deaths in infancy Arch. Dis. Child., January 1, 2005; 90(1): 48 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Neff, S. J. Simmens, C. Evans, and D. Mendelowitz Prenatal Nicotine Exposure Alters Central Cardiorespiratory Responses to Hypoxia in Rats: Implications for Sudden Infant Death Syndrome J. Neurosci., October 20, 2004; 24(42): 9261 - 9268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Opdal and T. O. Rognum The Sudden Infant Death Syndrome Gene: Does It Exist? Pediatrics, October 1, 2004; 114(4): e506 - e512. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dales, R. T. Burnett, M. Smith-Doiron, D. M. Stieb, and J. R. Brook Air Pollution and Sudden Infant Death Syndrome Pediatrics, June 1, 2004; 113(6): e628 - e631. [Abstract] [Full Text] |
||||
![]() |
H. Sawnani, T. Jackson, T. Murphy, R. Beckerman, and N. Simakajornboon The Effect of Maternal Smoking on Respiratory and Arousal Patterns in Preterm Infants during Sleep Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 733 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Spindel Neuronal nicotinic acetylcholine receptors: not just in brain Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1201 - L1202. [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Writing a Review Article for AJRCCM Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 732 - 734. [Full Text] [PDF] |
||||
![]() |
S R. Meadow Hazards in the epidemiological study of sudden infant death syndrome Arch. Dis. Child., May 1, 2003; 88(5): 460 - 461. [Full Text] [PDF] |
||||
![]() |
Committee on Fetus and Newborn Apnea, Sudden Infant Death Syndrome, and Home Monitoring Pediatrics, April 1, 2003; 111(4): 914 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
A B Chang, S J Wilson, I B Masters, M Yuill, J Williams, G Williams, and M Hubbard Altered arousal response in infants exposed to cigarette smoke Arch. Dis. Child., January 1, 2003; 88(1): 30 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Anderson Top Ten List in Sleep Chest, October 1, 2002; 122(4): 1457 - 1460. [Full Text] [PDF] |
||||
![]() |
T. Gislason, J. H. Johannsson, A. Haraldsson, B. R. Olafsdottir, H. Jonsdottir, A. Kong, M. L. Frigge, G. M. Jonsdottir, H. Hakonarson, J. Gulcher, et al. Familial Predisposition and Cosegregation Analysis of Adult Obstructive Sleep Apnea and the Sudden Infant Death Syndrome Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 833 - 838. [Abstract] [Full Text] |
||||
![]() |
M. J. TOBIN Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, and Pulmonary Function Testing in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 584 - 597. [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |